11C-choline PET/CT
Biochemical failure
Prostate cancer
Survival
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
16
11
2018
accepted:
26
12
2018
pubmed:
12
1
2019
medline:
19
5
2020
entrez:
12
1
2019
Statut:
ppublish
Résumé
The main drawback of This retrospective study included 210 PCa patients treated with radical prostatectomy who underwent Median follow-up after radical prostatectomy was 6.9 years (95% confidence interval, CI, 2.0-14.5 years). Despite the relatively low positive detection rate for PSA < 1 ng/ml, positive
Identifiants
pubmed: 30631911
doi: 10.1007/s00259-018-4253-3
pii: 10.1007/s00259-018-4253-3
doi:
Substances chimiques
Carbon Radioisotopes
0
Carbon-11
0
Prostate-Specific Antigen
EC 3.4.21.77
Choline
N91BDP6H0X
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
921-929Références
J Urol. 2003 Apr;169(4):1337-40
pubmed: 12629355
J Clin Oncol. 2005 Oct 1;23(28):6992-8
pubmed: 16192586
BJU Int. 2007 Jun;99(6):1415-20
pubmed: 17428249
J Clin Oncol. 2007 May 1;25(13):1765-71
pubmed: 17470867
Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):18-23
pubmed: 17891394
J Nucl Med. 2009 Sep;50(9):1394-400
pubmed: 19690023
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):301-9
pubmed: 19756592
Radiology. 2010 Mar;254(3):925-33
pubmed: 20177103
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1106-16
pubmed: 20306038
J Urol. 2010 Sep;184(3):938-43
pubmed: 20643445
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):55-63
pubmed: 20848281
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):53-4
pubmed: 21103870
Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):589-96
pubmed: 22231016
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):936-43
pubmed: 22415598
Eur Urol. 2013 Jun;63(6):1040-8
pubmed: 23036576
Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):149-55
pubmed: 23151910
J Urol. 2013 Jan;189(1):105-10
pubmed: 23164385
Clin Nucl Med. 2013 May;38(5):305-14
pubmed: 23486334
Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:S28-35
pubmed: 23576101
Eur Urol. 2013 Jul;64(1):106-17
pubmed: 23628493
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20
pubmed: 24072344
Eur Urol. 2014 Jan;65(1):124-37
pubmed: 24207135
Eur Urol. 2014 Feb;65(2):467-79
pubmed: 24321502
J Nucl Med. 2014 Feb;55(2):233-41
pubmed: 24408897
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1270-9
pubmed: 24599378
J Nucl Med. 2014 Jun;55(6):905-10
pubmed: 24676753
Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2222-31
pubmed: 25182750
Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2242-8
pubmed: 25186430
Eur J Nucl Med Mol Imaging. 2015 May;42(6):877-84
pubmed: 25697127
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1276-83
pubmed: 25808631
J Nucl Med. 2015 Aug;56(8):1185-90
pubmed: 26112024
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):84-91
pubmed: 26323576
J Nucl Med. 2015 Dec;56(12):1836-42
pubmed: 26405166
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):55-69
pubmed: 26450693
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):52-54
pubmed: 26475307
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1418-24
pubmed: 26791373
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1971-9
pubmed: 27277279
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2105-2113
pubmed: 27317482
Eur Urol. 2016 Dec;70(6):926-937
pubmed: 27363387
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):92-101
pubmed: 27557844
J Nucl Med. 2016 Oct;57(Suppl 3):43S-48S
pubmed: 27694171
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1751-1776
pubmed: 28409220
Eur Urol Focus. 2018 Sep;4(5):686-693
pubmed: 28753806
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):348-354
pubmed: 29110067